Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse model
NIU, ET AL. 2019. EMERG MICROBES INFECT 8(1):749-759
RESOURCES
Where research scientists come to find up to date resources on antibody discovery against challenging membrane protein targets.
Category: Publications
Broadly Neutralizing Antibodies Targeting New Sites of Vulnerability in Hepatitis C Virus E1E2
COLBERT, ET AL. 2019. J VIROL, DOI: 10.1128/JVI.02070-18
Human antibody response to Zika targets type-specific quaternary structure epitopes
COLLINS, ET AL. 2019. JCI INSIGHT 4(8):E124588
Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes
LI, ET AL. 2019. PLOS PATHOG 15(6):E1007716
Early human B cell response to Ebola virus in four U.S. survivors of infection
WILLIAMSON, ET AL. 2019. J VIROL, DOI:10.1128/JVI.01439-18
Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes
FOX, ET AL. 2019. SCI IMMUNOL, 4(32): EAAV5062
Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope
LONG, ET AL. 2019. PNAS DOI: 10.1073/PNAS.1815432116.
Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth
CHUKWUMA, ET AL. 2018. PLOS ONE 13(12), E0209437.
Broadly neutralizing antibody mediated clearance of human hepatitis C virus infection
KINCHEN, ET AL. 2018. CELL HOST MICROBE 24:717-730.
